SE9202968L - Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter - Google Patents

Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter

Info

Publication number
SE9202968L
SE9202968L SE9202968A SE9202968A SE9202968L SE 9202968 L SE9202968 L SE 9202968L SE 9202968 A SE9202968 A SE 9202968A SE 9202968 A SE9202968 A SE 9202968A SE 9202968 L SE9202968 L SE 9202968L
Authority
SE
Sweden
Prior art keywords
influenza
peptides
virus
antigens
viruses
Prior art date
Application number
SE9202968A
Other languages
English (en)
Other versions
SE9202968D0 (sv
Inventor
S Viazov
J Blomberg
E Isaeva
R Pipkorn
Original Assignee
Replico Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Replico Medical Ab filed Critical Replico Medical Ab
Priority to SE9202968A priority Critical patent/SE9202968L/sv
Publication of SE9202968D0 publication Critical patent/SE9202968D0/sv
Priority to AU52891/93A priority patent/AU5289193A/en
Priority to PCT/SE1993/000818 priority patent/WO1994009035A1/en
Publication of SE9202968L publication Critical patent/SE9202968L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SE9202968A 1992-10-09 1992-10-09 Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter SE9202968L (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9202968A SE9202968L (sv) 1992-10-09 1992-10-09 Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter
AU52891/93A AU5289193A (en) 1992-10-09 1993-10-11 New influenza virus peptides, diagnostics and vaccines
PCT/SE1993/000818 WO1994009035A1 (en) 1992-10-09 1993-10-11 New influenza virus peptides, diagnostics and vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9202968A SE9202968L (sv) 1992-10-09 1992-10-09 Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter

Publications (2)

Publication Number Publication Date
SE9202968D0 SE9202968D0 (sv) 1992-10-09
SE9202968L true SE9202968L (sv) 1994-04-10

Family

ID=20387437

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9202968A SE9202968L (sv) 1992-10-09 1992-10-09 Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter

Country Status (3)

Country Link
AU (1) AU5289193A (sv)
SE (1) SE9202968L (sv)
WO (1) WO1994009035A1 (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1843158A1 (de) * 2006-04-05 2007-10-10 Micronas Holding GmbH Nachweissystem für Krankheitserreger
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
EP2772267B1 (en) 2007-08-27 2016-04-27 Longhorn Vaccines and Diagnostics, LLC Immunogenic compositions and methods
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
EP3020832A1 (en) 2007-10-01 2016-05-18 Longhorn Vaccines and Diagnostics, LLC Biological specimen collection and transport system and methods of use
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
CA2863083C (en) 2012-01-26 2023-09-19 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
CA2985652C (en) 2015-05-14 2020-03-10 Gerald W. FISHER Rapid methods for the extraction of nucleic acids from biological samples
BR112020023354A2 (pt) * 2018-05-18 2021-02-09 Emergex Vaccines Holding Limited vacina de peptídeo reverso

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981782A (en) * 1987-05-14 1991-01-01 Sri International Synthetic peptides for diagnosis and prevention of influenza virus infection and their use

Also Published As

Publication number Publication date
WO1994009035A1 (en) 1994-04-28
AU5289193A (en) 1994-05-09
SE9202968D0 (sv) 1992-10-09

Similar Documents

Publication Publication Date Title
SE9202968L (sv) Nya peptider, diagnostiska antigener, deras användning, vacciner och medikamenter
RU94042722A (ru) Химерный белок, ген, клетка, вектор, способ получения химерного белка, вакцина
DK0610250T3 (da) Vaccine med porcint reproduktivt respiratorisk syndrom og diagnose heraf
NO871313D0 (no) Fremgangsmaate for fremstilling av virusvaksine.
DE69334192D1 (de) Papillomavirus vakzine
RU93058614A (ru) Мутант вируса герпеса, композиции, диагностические наборы, способы определения инфекции
RU96119986A (ru) Вакцина для предохранения свиньи от респираторных или репродуктивных заболеваний, содержащая парагриппозные вирусы
MY103575A (en) Cannie coronavirus vaccine
ATE20309T1 (de) Pharmazeutische zubereitung.
ATE320444T1 (de) Peptide, die die zytotoxische t-lymphozyte antwort gegen hepatitis-b-virus induzieren
AR004464A1 (es) Un metodo para producir una proteina de capside de papilomavirus
Rouse et al. Host defense mechanisms against infectious bovine rhinotracheitis virus: II. Inhibition of viral plaque formation by immune peripheral blood lymphocytes
SG55095A1 (en) Viruses and their use as a vaccine against feline infectious peritonitis virus disease
ATE109158T1 (de) Rubella-e1 und c peptide.
Cox The structural proteins of rabies virus
Lublin-Tennenbaum et al. Correlation between cutaneous reaction in vaccinees immunized against smallpox and antibody titer determined by plaque neutralization test and ELISA
SE9202318D0 (sv) Nya peptider, diagnostiska antigen, anvaendning daerav, vacciner och medikamenter
Arnon et al. Anti-influenza synthetic vaccine.
Velin et al. Systemic antibodies can inhibit mouse mammary tumor virus-driven superantigen response in mucosa-associated lymphoid tissues
Potgieter Pathogenesis of viral infections
Parra et al. IFN-γ Secreted by Virus-Specific CD8+ T Cells Contribute to CNS Viral Clearance
Berthold et al. Intrinsic interference caused by hepatitis sera
Dreizin et al. The use of indirect fluorescent antibody technique in studies on the reproduction of rhinoviruses and for the detection of rhinoviral antigen in materials from patients with acute respiratory diseases and conjunctivitides
TYa et al. Significance of long lasting persistence of influenza virus antigens at the portal of infection and in the spleen of mice
Mikhailov et al. The influence of gamma irradiation on hepatitis B virus components and delta antigen.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9202968-5

Effective date: 19941208